Aquinox Pharmaceuticals Announces Results From Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis
Go back to Aquinox Pharmaceuticals Announces Results From Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis| AQUINOX PHARMACEUT (NASDAQ: AQXP) | Delayed: 3.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.68 | 52 Week High | $15.76 | |||
| Open | $0.16 | 52 Week Low | $6.01 | |||
| Day High | $3.68 | P/E | N/A | |||
| Day Low | $3.68 | EPS | $0.00 | |||
| Volume | 0 | |||||
